|
Market Cap | 86.48M | EPS (ttm) | -7.15 |
P/E | - | EPS this Y | 26.08% |
Forward P/E | - | EPS next Y | 17.07% |
PEG | - | EPS past 5Y | - |
P/S | 0.12 | EPS next 5Y | - |
P/B | 0.38 | EPS Q/Q | 7.38% |
Dividend | - | Sales Q/Q | 1.33% |
Insider Own | 21.73% | Inst Own | 53.65% |
Insider Trans | 0.35% | Inst Trans | -7.97% |
Short Float | 2.76% | Earnings | May 09/b |
Analyst Recom | 1.67 | Target Price | 18.33 |
Avg Volume | 16.77K | 52W Range | 8.57 - 22.85 |
|
|
|
GoHealth, Inc. is a digital health company, which engages in the provision of insurance services. The firm's proprietary technology platform leverages machine-learning algorithms, powered by insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs. The company was founded by Clint P. Jones and Brandon M. Cruz in 2001 and is headquartered in Chicago, IL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
KOTTE VIJAY | Chief Executive Officer | Nov 13 '23 | Buy | 13.37 | 7,500 | 100,275 | 653,630 | Nov 15 10:10 AM |
|
|
|
|
Market Cap | 1.05M | EPS (ttm) | -7.16 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -96.30% |
P/S | 0.49 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -118.02% |
Dividend | - | Sales Q/Q | -70.05% |
Insider Own | 11.42% | Inst Own | 0.78% |
Insider Trans | 0.00% | Inst Trans | -82.22% |
Short Float | 3.46% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 9.63M | 52W Range | 0.09 - 1.22 |
|
|
|
Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom. |
|
|
|
Market Cap | 6.80M | EPS (ttm) | -24.54 |
P/E | - | EPS this Y | 76.01% |
Forward P/E | - | EPS next Y | 50.10% |
PEG | - | EPS past 5Y | 70.74% |
P/S | - | EPS next 5Y | - |
P/B | 0.55 | EPS Q/Q | 74.25% |
Dividend | - | Sales Q/Q | - |
Insider Own | 4.44% | Inst Own | 17.07% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.20% | Earnings | May 14/b |
Analyst Recom | 1.00 | Target Price | 32.50 |
Avg Volume | 108.77K | 52W Range | 3.45 - 61.20 |
|
|
|
Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC. |
|
| |
|
Market Cap | 115.36M | EPS (ttm) | 0.21 |
P/E | 84.38 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -26.80% |
P/S | 0.53 | EPS next 5Y | - |
P/B | 0.51 | EPS Q/Q | -228.32% |
Dividend | 3.61% | Sales Q/Q | -17.60% |
Insider Own | 7.65% | Inst Own | 69.68% |
Insider Trans | 0.00% | Inst Trans | -1.39% |
Short Float | 0.31% | Earnings | Jan 05/b |
Analyst Recom | 3.00 | Target Price | 38.00 |
Avg Volume | 28.02K | 52W Range | 17.59 - 28.20 |
|
|
|
Hurco Cos., Inc. is an international industrial technology company, which engages in the design, manufacture, and sale of computerized machine tools. It also offers machine tool components, software options, control upgrades, and accessories and replacement parts for its products, as well as customer service and training and applications support. The company was founded by Edward Humston and Gerald V. Roch in 1968 and is headquartered in Indianapolis, IN. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DOAR MICHAEL | Executive Chairman | Sep 20 '23 | Buy | 21.59 | 9,200 | 198,628 | 183,150 | Sep 20 05:17 PM | Wright Jonathon D. | General Counsel/Corp Secretary | Sep 18 '23 | Buy | 21.63 | 460 | 9,950 | 3,621 | Sep 19 03:25 PM | Porter Richard R. | Director | Sep 18 '23 | Sale | 21.60 | 2,430 | 52,488 | 10,573 | Sep 19 03:26 PM | Volovic Gregory S | President & CEO | Sep 15 '23 | Buy | 21.30 | 2,357 | 50,204 | 76,651 | Sep 15 06:27 PM | Jamison HaiQuynh | Corporate Controller | Sep 15 '23 | Buy | 21.27 | 461 | 9,805 | 3,627 | Sep 15 05:27 PM |
|
|
|
|
Market Cap | 2.35M | EPS (ttm) | -77.72 |
P/E | - | EPS this Y | 69.16% |
Forward P/E | - | EPS next Y | 49.47% |
PEG | - | EPS past 5Y | 32.73% |
P/S | 0.17 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 91.17% |
Dividend | - | Sales Q/Q | 32.77% |
Insider Own | 12.96% | Inst Own | 1.51% |
Insider Trans | -29.03% | Inst Trans | - |
Short Float | 22.72% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 40.00 |
Avg Volume | 593.51K | 52W Range | 3.62 - 89.60 |
|
|
|
Edible Garden AG, Inc. is a controlled environment agriculture (CEA) farming company, which engages in the usage of traditional agricultural growing techniques together with technology to grow organic food. Its products include lettuces, potted herbs, and cut herbs. The company was founded by James E. Kras and Michael C. James on March 28, 2020 and is headquartered in Belvidere, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
UBS Group AG | 10% Owner | Apr 25 '24 | Buy | 6.07 | 1,005 | 6,105 | 35,077 | May 03 12:04 PM | UBS Group AG | 10% Owner | Apr 25 '24 | Sale | 5.43 | 30,056 | 163,307 | 5,025 | May 03 12:04 PM | UBS Group AG | 10% Owner | Apr 24 '24 | Sale | 6.30 | 106 | 668 | 34,076 | May 03 12:04 PM | DonAroma Pamela | Director | Jun 02 '23 | Buy | 1.51 | 1,000 | 1,510 | 1,000 | Jun 06 04:30 PM | Kras James E. | President and CEO | May 18 '23 | Buy | 1.68 | 1,000 | 1,678 | 47,265 | May 19 05:10 PM |
|
|
| |
|
Market Cap | 1.91M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 30.61% |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | 132.21% |
Dividend | - | Sales Q/Q | - |
Insider Own | 2.25% | Inst Own | 10.66% |
Insider Trans | 0.00% | Inst Trans | -19.05% |
Short Float | 0.21% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 70.00 |
Avg Volume | 26.41K | 52W Range | 0.43 - 2.27 |
|
|
|
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel. |
|
|
|
Market Cap | 270.24M | EPS (ttm) | -2.10 |
P/E | - | EPS this Y | -65.00% |
Forward P/E | - | EPS next Y | 63.15% |
PEG | - | EPS past 5Y | 25.98% |
P/S | 0.85 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 11.03% |
Dividend | - | Sales Q/Q | 0.70% |
Insider Own | 16.88% | Inst Own | 61.29% |
Insider Trans | -3.24% | Inst Trans | 0.68% |
Short Float | 6.48% | Earnings | Mar 07/a |
Analyst Recom | 2.20 | Target Price | 14.50 |
Avg Volume | 414.92K | 52W Range | 7.08 - 18.19 |
|
|
|
Domo, Inc. designs, develops, and markets executive management software solutions. It offers customized software tools for business operations, customer relationship management, human resources, and financial reporting. The company was founded by Joshua G. James in September 2010 and is headquartered in American Fork, UT. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Jolley David R | Chief Financial Officer | Apr 11 '24 | Sale | 8.50 | 12,000 | 102,000 | 215,543 | Apr 12 04:40 PM | Thayne Daren | CTO & EVP of Product | Apr 04 '24 | Sale | 9.04 | 22,500 | 203,292 | 343,758 | Apr 05 04:45 PM | Thayne Daren | CTO & EVP of Product | Mar 22 '24 | Sale | 9.59 | 2,866 | 27,489 | 365,958 | Mar 22 07:31 PM | James Joshua G | Founder and CEO | Mar 21 '24 | Sale | 9.38 | 107,000 | 1,003,232 | 881,765 | Mar 22 07:21 PM | Thayne Daren | CTO & EVP of Product | Mar 21 '24 | Sale | 9.33 | 41,218 | 384,605 | 368,824 | Mar 22 07:31 PM |
|
|
| |
|
Market Cap | 361.20M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | - | Inst Own | - |
Insider Trans | - | Inst Trans | - |
Short Float | - | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 8.04M | 52W Range | 10.06 - 10.09 |
|
|
GP-Act III Acquisition Corp. operates as a blank check company, which was created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on November 23, 2020 and is headquartered in New York, NY. |
|
|
|
Market Cap | 63.36M | EPS (ttm) | -0.59 |
P/E | - | EPS this Y | 13.72% |
Forward P/E | - | EPS next Y | 4.47% |
PEG | - | EPS past 5Y | - |
P/S | 5.42 | EPS next 5Y | - |
P/B | 0.84 | EPS Q/Q | 20.22% |
Dividend | - | Sales Q/Q | 25.05% |
Insider Own | 34.13% | Inst Own | 11.45% |
Insider Trans | -0.02% | Inst Trans | -5.16% |
Short Float | 2.69% | Earnings | May 13/a |
Analyst Recom | 2.33 | Target Price | 1.27 |
Avg Volume | 87.37K | 52W Range | 0.76 - 3.28 |
|
|
May-14-24 03:04AM
|
Hyperfine Inc (HYPR) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth and Challenges
(GuruFocus.com) +10.14% |
May-13-24 08:53PM
|
HYPR Stock Earnings: Hyperfine Beats EPS, Beats Revenue for Q1 2024
(InvestorPlace) |
05:15PM
|
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Tops Revenue Estimates
(Zacks) |
04:05PM
|
Hyperfine, Inc. Reports First Quarter 2024 Financial Results
(GlobeNewswire) |
May-10-24 09:00AM
|
Hyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European Markets
(Business Wire) |
May-06-24 10:00AM
|
Will Hyperfine, Inc. (HYPR) Report Negative Earnings Next Week? What You Should Know
(Zacks) |
Apr-29-24 04:05PM
|
Hyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024
(Business Wire) |
Apr-25-24 09:35AM
|
Down -19% in 4 Weeks, Here's Why Hyperfine (HYPR) Looks Ripe for a Turnaround
(Zacks) |
Apr-23-24 09:00AM
|
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop System Images Across Multiple Care Settings and Clinical Conditions
(Business Wire) |
Apr-17-24 09:00AM
|
Leading Institutions Enroll First Alzheimers Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
(Business Wire) -8.08% |
|
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. It also develops imaging of health conditions through its Swoop portable magnetic resonance. The company was founded by Jonathan M. Rothberg and Ronald Walsworth on February 25, 2014 and is headquartered in Guilford, CT. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
TEISSEYRE THOMAS | Chief Operating Officer | Feb 16 '24 | Sale | 1.11 | 3,230 | 3,585 | 96,526 | Feb 16 04:06 PM | TEISSEYRE THOMAS | Chief Operating Officer | Nov 16 '23 | Sale | 1.26 | 2,655 | 3,345 | 99,756 | Nov 17 07:34 PM | TEISSEYRE THOMAS | Chief Operating Officer | Aug 16 '23 | Sale | 2.26 | 2,785 | 6,294 | 102,411 | Aug 17 04:45 PM | Siddiqui Khan | CMO and Chief Strategy Officer | Aug 16 '23 | Sale | 2.26 | 1,729 | 3,908 | 76,981 | Aug 17 04:44 PM | Siddiqui Khan | CMO and Chief Strategy Officer | May 16 '23 | Sale | 1.25 | 1,735 | 2,169 | 78,710 | May 16 06:15 PM |
|
|
|
|
Market Cap | 13.95M | EPS (ttm) | -0.50 |
P/E | - | EPS this Y | 40.82% |
Forward P/E | - | EPS next Y | 41.38% |
PEG | - | EPS past 5Y | - |
P/S | 0.74 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -17.74% |
Dividend | - | Sales Q/Q | -43.89% |
Insider Own | 22.57% | Inst Own | 6.73% |
Insider Trans | 0.00% | Inst Trans | -7.07% |
Short Float | 0.66% | Earnings | Nov 15/b |
Analyst Recom | 1.00 | Target Price | 1.00 |
Avg Volume | 175.79K | 52W Range | 0.28 - 1.28 |
|
|
|
Splash Beverage Group, Inc. engages in the sale and production of natural and healthy drinks. It offers products under the brands of TapouT, Salt Tequila, Copa Di Vino, and Pulpoloco Sangria. The company was founded on September 3, 1992 and is headquartered in Fort Lauderdale, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Nistico Robert | CEO and Chairman | Jun 16 '23 | Buy | 1.01 | 7,000 | 7,070 | 1,386,000 | Jun 16 11:19 AM |
|
|
|